CRS Clinical Research Services Berlin GmbH

Berlin 13627

0 studies enrolling now · 5 studies all time

What they study most

Atopic Dermatitis (AD), COVID-19, Plaque Psoriasis, SARS-CoV-2 Infection

Studies at this site

• A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis — Running, not enrolling
• A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2) — Running, not enrolling
• A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet) — Running, not enrolling
• A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis — Completed
• Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals — Completed